SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 13.221
NA - Nord America 1.025
AS - Asia 822
SA - Sud America 124
AF - Africa 23
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.218
Nazione #
IT - Italia 12.884
US - Stati Uniti d'America 984
SG - Singapore 344
CN - Cina 225
VN - Vietnam 95
BR - Brasile 87
SE - Svezia 78
DE - Germania 51
FI - Finlandia 43
FR - Francia 40
GB - Regno Unito 33
IN - India 33
CA - Canada 28
HK - Hong Kong 23
NL - Olanda 20
KR - Corea 14
AT - Austria 13
BD - Bangladesh 12
PL - Polonia 12
IE - Irlanda 10
IQ - Iraq 10
MX - Messico 10
AR - Argentina 9
CO - Colombia 8
EC - Ecuador 8
PH - Filippine 8
BE - Belgio 7
ES - Italia 7
VE - Venezuela 7
ZA - Sudafrica 7
ID - Indonesia 6
IR - Iran 6
TR - Turchia 6
IL - Israele 5
JP - Giappone 5
PK - Pakistan 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
TH - Thailandia 4
KE - Kenya 3
KG - Kirghizistan 3
UZ - Uzbekistan 3
AU - Australia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GA - Gabon 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
RU - Federazione Russa 2
UA - Ucraina 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.218
Città #
Cagliari 12.160
Uta 605
Singapore 206
Ashburn 156
San Jose 106
Dallas 82
Boardman 52
Chandler 45
Los Angeles 42
Nyköping 41
Beijing 40
Council Bluffs 36
The Dalles 35
Fairfield 33
Helsinki 32
New York 31
Ho Chi Minh City 30
Rome 27
Hanoi 25
Hefei 20
Hong Kong 19
Santa Clara 19
Munich 18
Shanghai 17
Seattle 16
Seoul 14
Amsterdam 13
Houston 12
Lauterbourg 12
Orem 12
Guangzhou 11
Pune 11
Buffalo 10
Düsseldorf 10
Montreal 10
Shenzhen 10
Boston 9
San Diego 9
Warsaw 9
Chicago 8
Dublin 8
Frankfurt am Main 8
Nuremberg 8
Redondo Beach 8
São Paulo 8
Wilmington 8
Haiphong 7
Woodbridge 7
Cambridge 6
London 6
Stockholm 6
Toronto 6
Turku 6
Vienna 6
Brooklyn 5
Lappeenranta 5
Manchester 5
Menlo Park 5
Mexico City 5
Milan 5
Zhengzhou 5
Bexley 4
Chennai 4
Da Nang 4
Denver 4
Dong Ket 4
Johannesburg 4
La Maddalena 4
Medellín 4
Paris 4
Rio de Janeiro 4
Roubaix 4
Selargius 4
Bishkek 3
Brussels 3
Buenos Aires 3
Charlotte 3
Karachi 3
Manila 3
Nairobi 3
Naples 3
Peristeri 3
Piscataway 3
Quito 3
Riyadh 3
San Francisco 3
Sassari 3
Tashkent 3
Tianjin 3
Washington 3
Wuhan 3
Al Hillah 2
Atlanta 2
Baghdad 2
Belo Horizonte 2
Bhubaneswar 2
Bắc Ninh 2
Calgary 2
Campinas 2
Caracas 2
Totale 14.306
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.773
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.365
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.224
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.200
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.088
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 997
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 964
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 941
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 756
Uncovering key targets of success for immunotherapy in pancreatic cancer 728
BRCA-mutant pancreatic ductal adenocarcinoma 620
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 606
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 595
Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated 311
Early taxane exposure and neurotoxicity in breast cancer patients 219
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 218
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 208
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 136
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 115
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 108
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 107
Totale 15.279
Categoria #
all - tutte 23.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/2022892 53 48 3 25 40 78 38 73 63 79 143 249
2022/20232.515 188 345 306 175 170 191 126 211 186 306 186 125
2023/20242.107 94 62 70 114 172 353 344 148 113 150 250 237
2024/20256.641 1.978 2.253 558 560 293 431 251 32 64 77 45 99
2025/20262.165 178 151 150 184 157 160 464 218 137 198 129 39
Totale 15.279